By Matthias Blamont PARIS (Reuters) - Sanofi SA said on Monday it would end its research efforts in diabetes and cardiovascular diseases as part of a revamp that will narrow the number of its business units in the hope of bolstering growth and profit.
The post Sanofi ends research in diabetes, narrows units to spur profit appeared first on Firstpost.
from Firstpost https://ift.tt/2Psg5OU
No comments:
Post a Comment